STOCK TITAN

Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Positron (OTC: POSC), a molecular imaging medical device company specializing in PET and PET-CT imaging systems, has announced its engagement with Skyline Corporate Communications Group to manage investor relations and corporate communications initiatives. Based in Boston and New York City, Skyline will help Positron effectively communicate its business strategies and market positioning to investors.

The engagement comes as Positron advances its PET-CT initiatives and moves toward commercialization in the nuclear imaging device industry. The company aims to become an SEC-reporting entity and pursue listing on a senior stock exchange. This partnership is expected to enhance Positron's market visibility and shareholder engagement while showcasing its innovative solutions and strategic milestones to the investment community.

Positron (OTC: POSC), un'azienda che si occupa di dispositivi medici per l'imaging molecolare specializzata in sistemi di imaging PET e PET-CT, ha annunciato il suo impegno con il Skyline Corporate Communications Group per gestire le relazioni con gli investitori e le iniziative di comunicazione aziendale. Con sede a Boston e New York City, Skyline aiuterà Positron a comunicare in modo efficace le sue strategie aziendali e il posizionamento di mercato agli investitori.

Questo impegno arriva mentre Positron sviluppa le sue iniziative PET-CT e si dirige verso la commercializzazione nell'industria dei dispositivi di imaging nucleare. L'azienda mira a diventare un'entità soggetta a reporting SEC e a perseguire la quotazione su una borsa valori di primo livello. Si prevede che questa partnership aumenterà la visibilità di mercato di Positron e il coinvolgimento degli azionisti, mettendo in mostra le sue soluzioni innovative e i traguardi strategici alla comunità degli investitori.

Positron (OTC: POSC), una empresa de dispositivos médicos de imagen molecular especializada en sistemas de imagen PET y PET-CT, ha anunciado su colaboración con el Skyline Corporate Communications Group para gestionar las relaciones con los inversores y las iniciativas de comunicación corporativa. Con sede en Boston y Nueva York, Skyline ayudará a Positron a comunicar eficazmente sus estrategias comerciales y su posicionamiento en el mercado a los inversores.

Este compromiso se produce mientras Positron avanza en sus iniciativas de PET-CT y se dirige hacia la comercialización en la industria de dispositivos de imagen nuclear. La empresa tiene como objetivo convertirse en una entidad que reporta a la SEC y perseguir la cotización en una bolsa de valores de altos estándares. Se espera que esta asociación mejore la visibilidad de mercado de Positron y el compromiso de los accionistas, al tiempo que presenta sus soluciones innovadoras y hitos estratégicos a la comunidad inversora.

Positron (OTC: POSC)는 PET 및 PET-CT 이미징 시스템을 전문으로 하는 분자 이미징 의료 기기 회사로, Skyline Corporate Communications Group와 투자자 관계 및 기업 커뮤니케이션 이니셔티브 관리에 대한 협력을 발표했습니다. 보스톤과 뉴욕시에 본사를 둔 Skyline은 Positron이 사업 전략과 시장 포지셔닝을 투자자에게 효과적으로 전달할 수 있도록 지원할 것입니다.

이번 협력은 Positron이 PET-CT 이니셔티브를 발전시키고 핵의학 기기 산업 내 상용화를 향해 나아가고 있는 가운데 이루어졌습니다. 이 회사는 SEC 보고 기관이 되고 고위 직장 상장 기회를 추구할 계획입니다. 이번 파트너십은 Positron의 시장 가시성과 주주 참여도를 높이고, 혁신적인 솔루션과 전략적 이정표를 투자 커뮤니티에 선보이는 데 기여할 것으로 예상됩니다.

Positron (OTC: POSC), une entreprise de dispositifs médicaux spécialisée dans l'imagerie moléculaire avec des systèmes d'imagerie PET et PET-CT, a annoncé son engagement avec Skyline Corporate Communications Group pour gérer les relations avec les investisseurs et les initiatives de communication corporate. Basée à Boston et New York, Skyline aidera Positron à communiquer efficacement ses stratégies commerciales et son positionnement sur le marché aux investisseurs.

Cette collaboration intervient alors que Positron fait progresser ses initiatives PET-CT et se dirige vers la commercialisation dans l'industrie des dispositifs d'imagerie nucléaire. La société vise à devenir une entité soumise au reporting de la SEC et à rechercher une cotation sur une bourse de valeur senior. Cette partenariat devrait améliorer la visibilité de Positron sur le marché et l'engagement des actionnaires, tout en mettant en avant ses solutions innovantes et ses étapes stratégiques auprès de la communauté d'investissement.

Positron (OTC: POSC), ein Unternehmen für molekulare Bildgebung, das sich auf PET- und PET-CT-Bildgebungssysteme spezialisiert hat, hat seine Zusammenarbeit mit Skyline Corporate Communications Group bekannt gegeben, um die Investorenbeziehungen und Unternehmenskommunikationsinitiativen zu verwalten. Mit Sitz in Boston und New York City wird Skyline Positron dabei helfen, seine Geschäftsstrategien und Marktpositionierung effektiv an die Investoren zu kommunizieren.

Diese Kooperation erfolgt, während Positron seine PET-CT-Initiativen vorantreibt und sich in Richtung Kommerzialisierung in der nuklearmedizinischen Geräteindustrie bewegt. Das Unternehmen strebt an, eine SEC-meldende Einheit zu werden und eine Notierung an einer führenden Börse zu verfolgen. Diese Partnerschaft soll die Marktpräsenz von Positron und das Engagement der Aktionäre verbessern und zugleich innovative Lösungen und strategische Meilensteine der Investmentgemeinschaft präsentieren.

Positive
  • Company is pursuing uplisting to a senior stock exchange
  • Moving toward SEC-reporting status
  • Advancing to commercialization phase
  • Expanding PET-CT initiatives
Negative
  • None.

Niagara Falls, NY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to announce that it has engaged Skyline Corporate Communications Group, LLC (“Skyline”) to oversee its investor relations and corporate communications initiatives within the financial community.

Skyline Corporate Communications Group, based in Boston and New York City, is a premier investor relations and corporate communications firm specializing in delivering strategic messaging and investor outreach for public companies. With extensive experience in the financial markets, Skyline helps companies effectively convey their business strategies, market positioning, and competitive advantages to investors, thereby enhancing market visibility and shareholder engagement.

Positron’s President, Adel Abdullah, commented, “Our recent product developments, progress and expanding growth objectives with our PET-CT initiatives prompted us to engage Skyline as our investor relations partner. Skyline's strong reputation and proven communication methodologies make them an ideal fit for Positron as we transition into our commercialization phase in the nuclear imaging device industry. Their expertise will be a valuable resource to ensuring our corporate message resonates with the investing public, especially as we advance toward becoming a SEC-reporting company and pursue listing on a senior stock exchange.”

By aligning with Skyline, Positron is positioned to strengthen its communication strategy, showcasing its innovative solutions and strategic milestones to current and potential investors as the Company expands its presence and executes its objectives in the medical imaging market.

About Positron Corporation
Positron Corporation is a medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America.

Positron specializes in the field of cardiac Positron Emission Tomography (PET) imaging, the gold standard in cardiac diagnostics. Positron’s innovative PET/PET-CT technologies, clinical services and practice solutions enables healthcare providers to accurately diagnose coronary artery disease and improve patient outcomes while practicing cost effective medicine.

Positron's Attrius® PET and NeuSight PET-CT imaging systems and distinct market position are substantial advantages unique to Positron that will facilitate the adoption of cardiac PET and the growth of the nuclear imaging market. Positron will soon offer a state-of-the-art PET-CT 4D molecular imaging device in the Affinity PET-CT 4D 64-Slice. Positron’s PET-CT(s) will enable nuclear cardiologists to utilize the full capabilities of molecular imaging and nuclear medicine. Positron’s PET-CT systems will also enable the Company to fully service and meet the demands of the vast oncology imaging segment of nuclear medicine.

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its co-developer, supplier, and R&D venture with Shenyang Intelligent Neuclear Technology Co. a subsidiary of Neusoft Medical Systems.

Please visit the Company’s website at: www.positron.com

About Skyline Corporate Communications Group, LLC
Skyline Corporate Communications Group, LLC provides strategic investor relations and corporate communications advisory services to public and late stage pre-IPO private companies globally. Our team has worked with hundreds of U.S. listed public companies from around the globe across diverse industries and various market caps. We have experience with shareholder activism and crisis communications, and also work with late-stage private companies to help prepare them to enter the public marketplace.

Please visit Skyline’s website at: www.skylineccg.com

Forward-Looking Statements
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Positron Corporation, and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

FOR FURTHER INFORMATION, please visit the company’s website at www.positron.com, or contact:

Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Lisa Gray, Senior Account Manager
One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: lisa@skylineccg.com 


FAQ

What are Positron 's (POSC) plans for uplisting its stock?

Positron plans to become an SEC-reporting company and pursue listing on a senior stock exchange, though specific timing details were not disclosed in the announcement.

What is Positron 's (POSC) current business focus?

Positron focuses on molecular imaging medical devices, offering PET and PET-CT imaging systems and clinical services in the nuclear imaging device industry.

Why did Positron (POSC) engage Skyline Corporate Communications Group?

Positron engaged Skyline to enhance its investor relations and corporate communications initiatives as it transitions into its commercialization phase and pursues listing on a senior stock exchange.

What stage is Positron (POSC) at in its commercialization process?

According to the announcement, Positron is transitioning into its commercialization phase in the nuclear imaging device industry while expanding its PET-CT initiatives.

POSITRON CORP

OTC:POSC

POSC Rankings

POSC Latest News

POSC Stock Data

25.93M
23.43M
Medical Devices
Healthcare
Link
United States of America
Niagara Falls